Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SMBC Nikko Downgrades Orchard Therapeutics to Neutral

SMBC Nikko downgrades Orchard Therapeutics (NASDAQ:ORTX) from Outperform to Neutral.
byBenzinga Newsdesk
April 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SMBC Nikko downgrades Orchard Therapeutics (NASDAQ:ORTX) from Outperform to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0